SEC Form D private-offering filing

Ensho Therapeutics, Inc.

Name: Ensho Therapeutics, Inc. - new SEC Form D private-offering filing, Woodcliff Lake, NJ
Published: 2026-02-09

A new SEC Form D private-offering notice from Woodcliff Lake, NJ, a $20,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Ensho Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing oral small molecule alpha4beta7 integrin inhibitors for inflammatory bowel disease, including ulcerative colitis and Crohn's disease.

Filed 2026-02-09Filed to raise $20,000,000First money in 2026-01-20HQ (as filed) Woodcliff Lake, NJSector Biotech ✓Stage (inferred) EarlyCall status No reported sale

Source linked the Form D on EDGAR↗Website verified enshorx.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.